Petros Pharmaceuticals

New York, United States

Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.

$9.6M raised

Feb 2025

Post-IPO Equity

Biotechnology Health Care Men's Pharmaceutical

Top Investors

Juggernaut Capital Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Petros Pharmaceuticals

How much funding has Petros Pharmaceuticals raised?

Petros Pharmaceuticals has raised $9.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.

Who are Petros Pharmaceuticals's investors?

Petros Pharmaceuticals's investors include Juggernaut Capital Partners.

Where is Petros Pharmaceuticals headquartered?

Petros Pharmaceuticals is headquartered in New York, United States.

What does Petros Pharmaceuticals do?

Petros Pharmaceuticals focuses on identifying, developing, acquiring, and commercializing novel therapeutics for men's health issues.

What stage is Petros Pharmaceuticals at?

Petros Pharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 18, 2025.

MLA

"Petros Pharmaceuticals — Funding & Investors." VCBacked, February 18, 2025, https://www.vcbacked.co/company/petros-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2025). Petros Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/petros-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Petros Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/petros-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 18, 2025.